Maynard Um
-
-
-
-
-
-
-
Raymond James Starts Jazz Pharmaceuticals (JAZZ) at Outperform
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $235 at Needham
-
-
-
-
-
-
-
Jazz Pharmaceuticals reports positive Ziihera cancer trial results
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $209 at Baird
-
-
-
-
-
-
-
FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-TAJS for extensive-stage small cell lung cancer
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) PT Raised at RBC Capital on 'Meaningful Upside' Potential
-
-
-
-
-
-
-
Jazz Pharmaceuticals names Renee Gala as CEO, Bruce Cozadd to retire
-
396,351 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

